🔴 Citius Pharmaceuticals is trading 5.22% down today — no fresh company-specific explanation identified

Citius Pharmaceuticals is trading 5.22% down at $0.68, with no fresh company-specific announcement identified to explain the August 12, 2026 decline.

• The stock is reversing part of the prior session’s 6.35% gain to $0.72.
• The latest notable catalyst was positive LYMPHIR commercial momentum reported August 5, including 78% quarter-over-quarter growth in ordering institutions; it does not explain today’s drop.
• Broader markets are modestly positive, making market-wide weakness unlikely to be the primary driver.